Phase 1 Study of the Safety and Immunogenicity of RiVax With Alum in Healthy Adults.

Trial Profile

Phase 1 Study of the Safety and Immunogenicity of RiVax With Alum in Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Ricin vaccine (Primary) ; Alum
  • Indications Ricin poisoning
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Aug 2012 Planned End Date changed from 1 Jan 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.
    • 03 Nov 2010 Status changed from recruiting to active, no longer recruiting, according to Soligenix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top